Data as of Sep 19
| +0.02 / +1.16%|
The 2 analysts offering 12-month price forecasts for Synthetic Biologics Inc have a median target of 6.75, with a high estimate of 7.50 and a low estimate of 6.00. The median estimate represents a +285.71% increase from the last price of 1.75.
The current consensus among 2 polled investment analysts is to Buy stock in Synthetic Biologics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.